Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes

Thrombosis Research

Volumn 116, Issue 6, 2005, Pages 465-470

  Abaci, Adnan ^a,c   Yilmaz, Yucel ^b   Caliskan, Mustafa ^b   Bayram, Fahri ^b   Cetin, Mustafa ^b   Unal, Ali ^b   Cetin, Servet ^b  

^a GAZI UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Aspirin; Diabetes; Function; Platelet

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

ADULT; ASPIRIN; BLOOD COAGULATION TESTS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TIME FACTORS;

EID: 24944558039     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.02.005     Document Type: Article

References (29)

1. Antithrombotic Trialists′ Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
2. E.M. Antman, D.T. Anbe, P.W. Armstrong, E.R. Bates, L.A. Green, and M. Hand ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines Circulation 110 2004 588 636
3. R.J. Gibbons, J. Abrams, K. Chatterjee, J. Daley, P.C. Deedwania, and J.S. Douglas ACC/AHA 2002 guidelines update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 107 2003 149 158
4. American Diabetes Association Aspirin therapy in diabetes Diabetes Care 23 Suppl. 1 2000 S61 S62
5. J.F. Mustard, and M.A. Packham Platelets and diabetes mellitus N Engl J Med 311 1984 665 667
6. G. Di Minno, M.J. Silver, A.M. Cerbone, G. Riccardi, A. Rivellese, and M. Mancini Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane Blood 65 1985 156 162
7. G. Davi, G.B. Rini, M. Averna, S. Novo, G. Di Fede, and A. Pinto Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics Thromb Res 26 1982 359 370
8. D. Aronson, E.J. Rayfield, and J.H. Chesebro Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction Ann Intern Med 126 1997 296 306
9. D.S.H. Bell Diabetes mellitus and coronary disease Coron Artery Dis 7 1996 715 722
10. T.A. Mori, R. Vandongen, A.J. Douglas, R.K. McCulloch, and V. Burke Differential effect of aspirin on platelet aggregation in IDDM Diabetes 41 1992 261 266
11. C. Watala, J. Golanski, J. Pluta, M. Boncler, M. Rozalski, and B. Luzak Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control Thromb Res 113 2004 101 113
12. A. Fujimura, K. Ohashi, and A. Ebihara Daily variations in platelet aggregation and adhesion in healthy subjects Life Sci 50 1992 1043 1047
13. E.F. Mammen, P.C. Comp, R. Gosselin, C. Greenberg, W.K. Hoots, and C.M. Kessler PFA-100 system: a new method for assessment of platelet dysfunction Semin Thromb Hemost 24 1998 195 202
14. S.K. Kundu, E.J. Heilman, R. Sio, C. Garcia, and R.A. Ostgaard Characterization of an in vitro platelet function analyzer, PFA-100™ Clin Appl Thromb/Hemost 2 1996 241 249
15. M. Homoncik, B. Jilma, N. Hergovich, P. Stohlawetz, S. Panzer, and W. Spelser Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100 Thromb Haemost 83 2000 316 321
16. B.B. Weksler, S.B. Pett, D. Alonso, R.C. Richter, P. Stelzer, and V. Subramanian Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients N Engl J Med 308 1983 800 805
17. K.K. Hampton, C. Cerletti, L.A. Loizou, F. Bucchi, M.B. Donati, and J.A. Davies Coagülation, fibrinolytic, and platelet function in patients on long term therapy with aspirin 300 mg or 1200 mg daily compared with placebo Thromb Haemost 64 1990 17 20
18. M. Sacco on behalf of the PPP Collaborative Group Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients Diabetes Care 26 2003 3264 3272
19. A.H. Boss, G. Boysen, and J.S. Olseen Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease Eur J Clin Invest 15 1985 412 414
20. S.F. Dabaghi, S.G. Kamat, J. Payne, G.F. Marks, R. Roberts, and A.I. Schafer Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects Am J Cardiol 74 1994 720 723
21. M.R. Buchanan, and S.J. Brister Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically Can J Cardiol 11 1995 221 227
22. C.M. Helgason, K.L. Tortorice, E.R. Winkler, D.W. Penney, J.J. Schuler, and T.J. McClelland Aspirin response and failure in cerebral infarction Stroke 24 1993 345 350
23. H. Tohgi, S. Konno, K. Tamura, B. Kimura, and K. Kawano Effect of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin Stroke 24 1992 1400 1403
24. S. Malhotra, Y.P. Sharma, A. Grover, S. Majumdar, S.M. Hanif, and V.K. Bhargava Effect of different aspirin doses on platelet aggregation in patients with stable coronary artery disease Intern Med J 33 2003 350 354
25. R. Gan, R.A. Teleg, L. Florento, and E.S. Bitanga Effect of increasing doses of aspirin on platelet aggregation among stroke patients Cerebrovasc Dis 14 2002 252 255
26. D. Feng, C. McKenna, J. Murillo, M.A. Mittleman, O.C. Gebara, and I. Lipinska Effect of aspirin dosage and enteric coating on platelet reactivity Am J Cardiol 80 1997 189 193
27. R.G. Hart, A.D. Leonard, K.L. Talbert, L.A. Pearce, E. Cornell, and E. Bovill Aspirin dosage and thromboxane synthesis in patients with vascular disease Pharamcotherapy 23 2003 579 584
28. S. Wong, M. Appleberg, C.M. Ward, and D.R. Lewis Aspirin resistance in cardiovascular disease: a review Eur J Vasc Endovasc Surg 27 2004 456 465
29. T. Chakroun, G. Gerotziafas, F. Robert, C. Lecrubier, M.M. Samama, and M. Hatmi In vitro aspirin resistance detected by PFA-100™ closure time: pivotal role of plasma von Willebrand factor Br J Haematol 124 2004 80 85